Skip to main content

Invesco Nasdaq Biotechnology ETF — Company Overview, News & Financial Data

Invesco Nasdaq Biotechnology ETF logo
Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF primary media
Company profile

Invesco Nasdaq Biotechnology ETF

About

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) is a fund that focuses on the biotechnology sector, aiming to track the investment results of an index composed of biotechnology and pharmaceutical companies listed on the NASDAQ. This ETF enables investors to gain exposure to a broad range of companies involved in the research, development, and distribution of innovative medical treatments and technologies. The main objective of the fund is to replicate the performance of the NASDAQ Biotechnology Index, thereby providing investment results that closely correspond, before fees and expenses, to the performance of its underlying index. Through its investments, the Invesco Nasdaq Biotechnology ETF plays a crucial role in supporting the growth and development of the biotech industry, offering a diversified portfolio that spans various markets and stages of the biotechnology development cycle.

Snapshot

2021Year founded
5023Employees
Atlanta, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
United States

Products and/or services of Invesco Nasdaq Biotechnology ETF

  • Provides diversified exposure to biotechnology and pharmaceutical companies.
  • Offers potential for long-term capital growth through investments in Nasdaq-listed biotech firms.
  • Aims for high-risk adjusted returns by investing in innovative healthcare solutions.
  • Seeks to mirror the performance of the NASDAQ Biotechnology Index.
  • Facilitates liquidity and accessibility for investors through exchange-traded fund structure.
  • Employs professional management with expertise in biotech sector investing.

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift